France· FR:66457697
LUVERIS 75 UI, poudre et solvant pour solution injectable
A medicinal product containing lutropine alfa, registered in France by MERCK EUROPE (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LUTROPINE ALFA
- Manufacturer
- MERCK EUROPE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009354964301 flacon en verre - 1 flacon en verre de 1 mLEUR 45.92
- cip1334009354966693 flacons en verre - 3 flacons en verre de 1 mLEUR 136.96
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutropine alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandLuveris 75 IU powder and solvent for solution for injectionMerck Europe B.V.
- BelgiumLuveris 450 IUMerck Europe
- CzechiaLUVERISMerck Europe B.V., Amsterdam
- ItalyLUVERIS*1 flaconcino SC 75 UI + 1 flaconcino solvMERCK EUROPE BV
- FinlandLuverisMerck Europe B.V.
- United KingdomLuveris 75unit powder and solvent for solution for injection vialsMerck Serono Ltd
- IcelandLuverisMerck Europe B.V.*
- PolandLuverisMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Luveris
- Liechtenstein · Luveris
- Norway · Luveris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42ed41fb-72d5-40a5-8ee1-a95b178d8536 GET /v1/drugs/42ed41fb-72d5-40a5-8ee1-a95b178d8536?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66457697",
"date_amm": "2000-11-29",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/00/155",
"substance": "LUTROPINE ALFA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about lutropine alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.